GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
US10046043B2 · kind B2 · utility
3Cited by
13References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2016 |
| Grant date | Aug 14, 2018 |
| Priority date | — |
| Expiry date | Aug 15, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/825
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally provides methods and compositions for eliciting an immune response against Neisseria spp. bacteria in a subject, particularly against a Neisseria meningitidis serogroup B strain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.